Steroid Therapy in Branch Retinal Vein Occlusion and Macular Edema

Vision Loss ◽

Treatment Modalities ◽

Vein Occlusion ◽

New Information ◽

Endothelial Growth Factor

Macular edema is the most common cause of vision loss in branch retinal vein occlusion. Mechanism of macular edema in branch retinal vein occlusion is multifactorial and it has not yet been fully understood. With the new information obtained from the new studies, treatment modalities have been changed. Nowadays besides laser and intravitreal triamcinolone acetonide treatments, intravitreal antivascular endothelial growth factor and dexamethasone implant therapies are commonly used. In this review, we aimed to evaluate the intravitreal steroid treatment in branch retinal vein occlusion.

Intravitreal Triamcinolone Acetonide for Patients with Macular Edema due to Branch Retinal Vein Occlusion

The Kaohsiung Journal of Medical Sciences ◽

10.1016/s1607-551x(09)70318-3 ◽

2006 ◽

Vol 22 (7) ◽

pp. 321-330 ◽

Cited By ~ 14

Author(s):

Kai-Chun Cheng ◽

Wen-Chuan Wu

Keyword(s):

Macular Edema ◽

Triamcinolone Acetonide ◽

Retinal Vein Occlusion ◽

The Efficacy of Intravitreal Triamcinolone Acetonide on Macular Edema in Branch Retinal Vein Occlusion

European Journal of Ophthalmology ◽

10.1177/112067210501500115 ◽

2005 ◽

Vol 15 (1) ◽

pp. 96-101 ◽

Cited By ~ 23

Author(s):

A. Özkiris ◽

C. Evereklioglu ◽

K. Erkiliç ◽

Ö. Ilhan

Keyword(s):

Macular Edema ◽

Triamcinolone Acetonide ◽

Retinal Vein Occlusion ◽

Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion

Indian Journal of Ophthalmology ◽

10.4103/0301-4738.105048 ◽

2013 ◽

Vol 61 (1) ◽

pp. 3 ◽

Cited By ~ 2

Author(s):

Murat Karacorlu ◽

SerraArf Karacorlu ◽

Hakan Ozdemir ◽

Fevzi Senturk ◽

Omer Uysal

Keyword(s):

Macular Edema ◽

Triamcinolone Acetonide ◽

Retinal Vein Occlusion ◽

Retinal Sensitivity ◽

Intravitreal Triamcinolone Acetonide Injection

Vein Occlusion ◽

Sensitivity Improvement ◽

Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology

BMC Ophthalmology ◽

10.1186/1471-2415-12-39 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 5

Author(s):

Hidetaka Noma ◽

Hideharu Funatsu ◽

Tatsuya Mimura ◽

Katsunori Shimada

Keyword(s):

Retinal Detachment ◽

Macular Edema ◽

Triamcinolone Acetonide ◽

Retinal Vein Occlusion ◽

Cystoid Macular Edema ◽

Serous Retinal Detachment ◽

A RANDOMIZED TRIAL COMPARING THE EFFICACY AND SAFETY OF INTRAVITREAL TRIAMCINOLONE WITH STANDARD CARE TO TREAT VISION LOSS ASSOCIATED WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

Evidence-Based Ophthalmology ◽

10.1097/ieb.0b013e3181c70dc3 ◽

2010 ◽

Vol 11 (1) ◽

pp. 22-23

Author(s):

William B. Benson

Keyword(s):

Randomized Trial ◽

Macular Edema ◽

Retinal Vein Occlusion ◽

Standard Care ◽

Vision Loss ◽

Efficacy And Safety ◽

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion

Archives of Ophthalmology ◽

10.1001/archophthalmol.2009.233 ◽

2009 ◽

Vol 127 (9) ◽

pp. 1115 ◽

Cited By ~ 293

Keyword(s):

Randomized Trial ◽

Macular Edema ◽

Retinal Vein Occlusion ◽

Standard Care ◽

Vision Loss ◽

Efficacy And Safety ◽

Error in Figure and Text in: A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion

Archives of Ophthalmology ◽

10.1001/archophthalmol.2009.346 ◽

2009 ◽

Vol 127 (12) ◽

pp. 1655

Keyword(s):

Randomized Trial ◽

Macular Edema ◽

Retinal Vein Occlusion ◽

Standard Care ◽

Vision Loss ◽

Efficacy And Safety ◽

Early versus Late Intravitreal Triamcinolone Acetonide for Macular Edema associated with Branch Retinal Vein Occlusion

Korean Journal of Ophthalmology ◽

10.3341/kjo.2007.21.1.18 ◽

2007 ◽

Vol 21 (1) ◽

pp. 18 ◽

Cited By ~ 17

Author(s):

Joo Youn Oh ◽

Je Hyun Seo ◽

Jae Kyoun Ahn ◽

Jang Won Heo ◽

Hum Chung

Keyword(s):

Macular Edema ◽

Triamcinolone Acetonide ◽

Retinal Vein Occlusion ◽

Steroids in the Treatment of Central Retinal Vein Occlusion

50 Studies Every Ophthalmologist Should Know ◽

10.1093/med/9780190050726.003.0024 ◽

2020 ◽

pp. 139-144

Author(s):

Alan D. Penman ◽

Kimberly W. Crowder ◽

William M. Watkins

Keyword(s):

Macular Edema ◽

Retinal Vein Occlusion ◽

Central Retinal Vein Occlusion ◽

Vision Loss ◽

Standard Of Care ◽

Vascular Endothelial ◽

Vein Occlusion ◽

Endothelial Growth Factor ◽

Central Retinal Vein

The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE-CRVO) Study was a randomized clinical trial comparing intravitreal triamcinolone to observation in eyes with vision loss associated with macular edema due to perfused (nonischemic) central retinal vein occlusion (CRVO). The results suggested that intravitreal triamcinolone in a 1-mg dose should be considered for up to 1 year, and possibly 2 years, in patients with vision loss associated with macular edema secondary to CRVO. The study was the first to establish an effective treatment for perfused CRVO. (Treatment with intravitreal anti–vascular endothelial growth factor [VEGF] agents has been shown to produce greater improvement in visual acuity and is now the standard of care.)